400 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Editas (EDIT) Q4 Earnings & Sales Fall Shy of Estimates http://www.zacks.com/stock/news/787247/editas-edit-q4-earnings-sales-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-787247 Feb 27, 2020 - Editas (EDIT) misses on earnings and revenues in fourth-quarter 2019.
Aerie's (AERI) Q4 Loss Wider Than Expected, Revenues Beat http://www.zacks.com/stock/news/777268/aeries-aeri-q4-loss-wider-than-expected-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-777268 Feb 21, 2020 - Aerie (AERI) reports a wider loss in the fourth quarter, while sales surpass expectations.
Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS http://www.zacks.com/stock/news/777113/zacks-value-trader-highlights-abbvie-allergan-occidental-chevron-and-cvs?cid=CS-ZC-FT-press_releases-777113 Feb 21, 2020 - Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS
One of Your Stock Investments is Being Acquired: Now What? http://www.zacks.com/stock/news/775278/one-of-your-stock-investments-is-being-acquired-now-what?cid=CS-ZC-FT-value_investor-775278 Feb 20, 2020 - One of your companies gets a buyout offer and the shares soar. There might be different strategies for traders and investors on what to do next.
17 Consumer Groups and Unions Ask FTC to Block AbbVie's Acquisition of Allergan https://www.fool.com/investing/2020/02/18/17-consumer-groups-and-unions-ask-ftc-to-block-abb.aspx?source=iedfolrf0000001 Feb 18, 2020 - The groups are worried about reduced competition if the merger goes through.
Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails http://www.zacks.com/stock/news/765605/pharma-stock-roundup-abbv-agn-post-q4-results-another-alzheimers-study-fails?cid=CS-ZC-FT-analyst_blog|stock_roundup-765605 Feb 14, 2020 - AbbVie (ABBV) and Allergan (AGN) announce Q4 results.
Teva (TEVA) Q4 Earnings In Line, Stock Up as Sales Stabilize http://www.zacks.com/stock/news/763728/teva-teva-q4-earnings-in-line-stock-up-as-sales-stabilize?cid=CS-ZC-FT-analyst_blog|earnings_article-763728 Feb 13, 2020 - Teva Pharmaceutical (TEVA) earnings match estimates but sales beat. Shares rise 9%.
Top Stock Analyst Reports for Merck, Philip Morris & American Tower http://www.zacks.com/research-daily/762105/top-stock-analyst-reports-for-merck-philip-morris-american-tower?cid=CS-ZC-FT-research_daily-762105 Feb 12, 2020 - Top Stock Analyst Reports for Merck, Philip Morris & American Tower
With Solid Fourth Quarter Results, AbbVie Shows That Its Growth Days Are Far From Over https://www.fool.com/investing/2020/02/11/with-solid-fourth-quarter-results-abbvie-shows-tha.aspx?source=iedfolrf0000001 Feb 11, 2020 - Despite Humira's declining international sales, AbbVie is still worth considering.
Company News for Feb 11, 2020 http://www.zacks.com/stock/news/760303/company-news-for-feb-11-2020?cid=CS-ZC--corporate_summary-760303 Feb 11, 2020 - Companies in the news are: QSR, CNA, MPAA, AGN

Pages: 123456...40

Page 1>